Colorectal Cancer in Inflammatory Bowel Disease

참고문헌 (77)

1. Crohn BB, "The sigmoidoscopic picture of chronic ulcerative colitis", Am J Med Sci, 170, pp.220~228 (1925)
2. Devroede GJ, "Cancer risk and life expectancy of children with ulcerative colitis", N Engl J Med, 285, pp.17~22 (1971)
3. Winther KV, "Survival and cause specific mortality in ulcerative colitis: follow-up of a population based cohort in Copenhagen County", Gastroenterology, 125, pp.1576~1582 (2003)
4. Eaden JA, "The risk of colorectal cancer in ulcerative colitis; a meta-analysis", Gut, 48, pp.526~535 (2001)
5. Palli D, "Hodgkins Disease risk is increased in patients with ulcerative colitis", Gastroenterology, 119, pp.647~653 (2000)
6. Bernstein CN, "Cancer risk in patients with inflammatory bowel disease; a population based study", Cancer, 91, pp.854~862 (2001)
7. Latkos L, "Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of patients with ulcerative colitis: results of a population based study", Inflamm Bowel Dis, 12, pp.205~211 (2006)
8. Loftus EV, "Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis", Gastroenterol Clin North Am, 35, pp.517~531 (2006)
9. Ekbom A, "Ulcerative colitis and colorectal cancer: a population based study", N Engl J Med, 323, pp.1228~1233 (1990)
10. Karlen P, "Increased risk of cancer in ulcerative colitis: a population based cohort study", Am J Gastroenterol, 94, pp.1047~1052 (1999)
11. Winther KV, "Long term risk of cancer in ulcerative colitis: a population based cohort study from Copenhagen county", Clin Gastroenterol Hepatol, 2, pp.1088~1095 (2004)
12. Jess T, "Risk of intestinal cancer in inflammatory bowel disease: a population based study from Olmsted County, Minnesota", Gastroenterology, 130, pp.1039~1046 (2006)
13. Lindberg J, "Efficiency of colorectal cancer surveillance in patients with ulcerative colitis; 26 years of experience in a patient cohort from a defined population area", Scand J Gastroenterol, 40, pp.1076~1080 (2005)
14. Jess T, "Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population based study from Olmsted County, Minnesota", Inflamm Bowel Dis, 12, pp.669~676 (2006)
15. Rutter MD, "Thirty year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis", Gastroenterology, 130, pp.1030~1038 (2006)
16. Bernstein CN, "Cancer risk in patients with inflammatory bowel disease: a population- based study", Cancer, 91, pp.854~862 (2001)
17. Choi PM, "Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention", Gut, 35, pp.950~954 (1994)
18. Ekbom A, "Ulcerative colitis and colorectal cancer: a population-based study", N Engl J Med, 323, pp.1228~1233 (1990)
19. Gyde SN, "Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres", Gut, 29, pp.206~217 (1988)
20. Heuschen UA, "Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis", Gastroenterology, 120, pp.841~847 (2001)
21. Haskell H, "Pathological features and clinical significance of backwash ileitis in ulcerative colitis", Am J Surg Pathol, 29, pp.1472~1481 (2005)
22. Rutter M, "Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis", Gastroenterology, 126, pp.451~459 (2004)
23. Gupta RB, "Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study", Gastroenterology, 133, pp.1099~1105 (2007)
24. Mathy C, "Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis", Inflamm Bowel Dis, 9, pp.351~355 (2003)
25. Kornfeld D, "Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study", Gut, 41, pp.522~525 (1997)
26. Shetty K, "The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis", Am J Gastroenterol, 94, pp.1643~1649 (1999)
27. Lundqvist K, "Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study", Dis Colon Rectum, 40, pp.451~461 (1997)
28. Pardi DS, "Ursodeoxycholic acid as a chemopreventative agent in patients with ulcerative colitis and primary sclerosing cholangitis", Gastroenterology, 124, pp.889~893 (2003)
29. Blackstone MO, "Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy", Gastroenterology, 80, pp.366~374 (1981)
30. Bernstein CN, "Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?", Lancet, 343, pp.71~74 (1994)
31. Rubin PH, "Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps", Gastroenterology, 117, pp.1295~1300 (1999)
32. Engelsgjerd M, "Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis", Gastroenterology, 117, pp.1288~1294 (1999)
33. Odze RD, "Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis", Clin Gastroenterol Hepatol, 2, pp.534~541 (2004)
34. Rubin CE, "DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis", Gastroenterology, 103, pp.1611~1620 (1992)
35. Bernstein CN, "Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis", Am J Gastroenterol, 90, pp.2106~2114 (1995)
36. Eaden JA, "How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of perfomance", Gastrointest Endosc, 51, pp.123~128 (2000)
37. Riddell RH, "Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications", Hum Pathol, 14, pp.931~968 (1983)
38. Itzkowitz SH, "Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease", Inflamm Bowel Dis, 11, pp.314~321 (2005)
39. Harpaz N, "Colorectal cancer in idiopathic inflammatory bowel disease", Semin Diagn Pathol, 13, pp.339~357 (1996)
40. Ullman TA, "Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis", Gastroenterology, 125, pp.1311~1319 (2003)
41. Connell WR, "Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis", Gastroenterology, 107, pp.934~944 (1994)
42. Lennard-Jones JE, "Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years", Gut, 31, pp.800~806 (1990)
43. Levi GS, "Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease", Am J Surg Pathol, 30, pp.1022~1029 (2006)
44. Ullman TA, "The fate of low grade dysplasia in ulcerative colitis", Am J Gastroenterol, 97, pp.922~927 (2002)
45. Befrits R, "Low-grade dysplasia in extensive, long-standing inflammatory bowel disease; a follow-up study", Dis Colon Rectum, 45, pp.615~620 (2002)
46. Lim CH, "Ten year follow up of ulcerative colitis patients with and without low grade dysplasia", Gut, 52, pp.1127~1132 (2003)
47. Karlen P, "Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study", Gut, 42, pp.711~714 (1998)
48. Eaden J, "Colorectal cancer prevention in ulcerative colitis: a casecontrol study", Aliment Pharmacol Ther, 14, pp.145~153 (2000)
49. Griffiths AM, "Colonoscopic surveillance for cancer in ulcerative colitis: a critical review", J Pediatr Gastroenterol Nutr, 24, pp.202~210 (1997)
50. Melville DM, "Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome", Hum Pathol, 20, pp.1008~1014 (1989)
51. Friedman S, "Screening and surveillance colonoscopy in chronic Crohn's colitis", Gastroenterology, 120, pp.820~826 (2001)
52. Friedman S, "Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years", Clin Gastroenterol Hepatol (2008)
53. Gumaste V, "Benign and malignant colorectal strictures in ulcerative colitis", Gut, 33, pp.938~941 (1992)
54. Kiesslich R, "Methylene blue aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis", Gastroenterology, 124, pp.880~888 (2003)
55. Rutter MD, "Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis", Gut, 53, pp.256~260 (2004)
56. Hurlstone DP, "Indigo carmine assisted high magnification chromoscopic colonoscopy for the detection and characterization of intraepithelial neoplasia and colon cancer in ulcerative colitis: a prospective evaluation", Endoscopy, 37, pp.1186~1192 (2005)
57. Marion JF, "Chromoendoscopy- targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial", Am J Gastroenterol (2008)
58. Dekker E, "Narrow band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis", Endoscopy, 39, pp.216~221 (2007)
59. Kiesslich R, "Chromoscopy guided endomicroscopy increases diagnostic yield of intraepithelial neoplasia in ulcerative colitis", Gastroenterology, 132, pp.874~882 (2007)
60. Matsumoto T, "Autoflourescence colonoscopy for the diagnosis of dysplasia in ulcerative colitis", Inflamm Bowel Dis, 13, pp.640~641 (2007)
61. Itzkowitz SH, "Diagnosis and management of dysplasia in patients with inflammatory bowel diseases", Gastroenterology, 126, pp.1634~1648 (2004)
62. Rubin DT, "Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update", Inflamm Bowel Dis, 14, pp.265~274 (2008)
63. Velayos FS, "Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study", Gastroenterology, 130, pp.1941~1949 (2006)
64. Matula S, "Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine", Clin Gastroenterol Hep, 3, pp.1015~1021 (2005)
65. Freudenheim J, "Folate intake and carcinogenesis of the colon and rectum", Int J Epidemiol, 20, pp.368~374 (1991)
66. Giovannucci E, "Folate, methionine, and alcohol intake and risk of colorectal adenoma", J Natl Cancer Inst, 85, pp.875~884 (1993)
67. Lashner BA, "Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis", Gastroenterology, 97, pp.255~259 (1989)
68. Lashner BA, "The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis", Gastroenterology, 112, pp.29~32 (1997)
69. Tung BY, "Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis", Ann Intern Med, 134, pp.89~95 (2001)
70. Pardi DS, "Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis", Gastroenterology, 124, pp.889~893 (2003)
71. Poynter JN, "Statins and the risk of colorectal cancer", N Engl J Med, 352, pp.2184~2192 (2005)
72. Gullberg K, "Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis", Gastroenterology, 112, pp.1487~1492 (1997)
73. Thompson-Fawcett MW, "Risk of dysplasia in Long-term ileal pouches and pouches with chronic pouchitis", Gastroenterology, 121, pp.275~281 (2001)
74. Herline AJ, "Is routine pouch surveillance for dysplasia indicated for ileoanal pouches?", Dis Colon Rectum, 46, pp.156~159 (2003)
75. O'Riordain MG, "Incidence and natural history of dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of a five-year to ten-year follow-up", Dis Colon Rectum, 43, pp.1660~1665 (2000)
76. Brentnall TA, "Molecular underpinnings of cancer in ulcerative colitis", Curr Opin Gastroenterol, 19, pp.64~68 (2003)
77. Itzkowitz SH, "Improved fecal DNA test for colorectal cancer screening", Clin Gastroenterol Hepatol, 5, pp.111~117 (2007)

관련 논문AI추천